PRESS RELEASE WASHINGTON, DC – The American Pharmacists Association recently published a guidebook, How to Put into action the Pharmacists’ Patient Care Procedure, that introduces the Pharmacists’ Patient Care Procedure. On the other hand with the uniform affected person care process other healthcare specialists are educated to provide, variability remains in the patient care process trained and practiced within the pharmacy profession. The Pharmacists’ Patient Care Process, adopted in May 2014 by the Joint Commission of Pharmacy Practitioners , describes a constant, contemporary and comprehensive method of patient-centered care that is delivered in collaboration with additional members of the health care team rx pharmacy .

‘Iclusig is now inside our distribution channel with Biologics, and our devoted sales force will begin promoting Iclusig immediately. We are highly assured inside our commercial launch of Iclusig and look forwards to reporting on our improvement on a quarterly basis.’ Last month, the U.S. Food and Medication Administration authorized revised U.S. Prescribing Details and a communications Risk Evaluation and Mitigation Strategy for Iclusig that allowed for the immediate resumption of its advertising and commercial distribution. The USPI carries a revised indication declaration and boxed warning, updated safety information and suggestions regarding dosing considerations for prescribers. Iclusig is currently indicated for the treating adult individuals with: T315I-positive chronic myeloid leukemia or T315I-positive Philadelphia chromosome positive acute lymphoblastic leukemia, or Chronic phase, accelerated stage, or blast phase persistent myeloid leukemia or Ph+ acute lymphoblastic leukemia for whom no other tyrosine-kinase inhibitor therapy is certainly indicated.